Genetic Evidence Supporting a Causal Association Between mTOR-Dependent EIF-4E Circulating Protein Level and Osteoporosis

Adv Ther. 2023 Nov;40(11):4987-4998. doi: 10.1007/s12325-023-02676-x. Epub 2023 Sep 20.

Abstract

Introduction: The mechanistic target of rapamycin (mTOR) regulates bone homeostasis, a crucial factor in osteoporosis (OP) development. However, most research is based on observational studies, and the causality remains uncertain. Therefore, we analyzed two samples of mendelian randomization (MR) to determine whether there is a causal relationship between mTOR-dependent circulating proteins and OP.

Methods: Mendelian weighting (weighted median [WM], inverse variance weighting [IVW], and MR-Egger regression) were applied to analyze the causality between bone phenotypes (bone mineral density [BMD] in forearm, femoral neck, lumbar spine, and heel) and mTOR-dependent circulating proteins (RP-S6K, 4EBP, EIF-4E, EIF-4A, and EIF-4G). Horizontal pleiotropy and heterogeneities were detected using Cochran's Q test, MR-Pleiotropy RE-Sidual Sum and Outlier (MR-PRESSO), and "leave-one-out" analysis. The proteomics-GWAS INTERVAL study was used to select the instrumental variables (IVs) for mTOR proteins.

Results: As phenotypes for OP, estimations of BMD were taken in four different sites: forearm (FA) (n = 8143), femoral neck (FN) (n = 32,735), lumbar spine (LS) (n = 28,498), and heel (eBMD) (n = 426,824). Based on IVW analysis, EIF4E is causally related to FA-BMD (OR = 0.938, 95% CI 0.887, 0.991, p = 0.024) but not to BMD elsewhere.

Conclusion: MR analysis revealed a causal relationship between EIF-4E and FA-BMD, which may provide new insights into the underlying pathogenesis of OP and a new therapeutic target for OP.

Keywords: Bone mineral density; Eukaryotic translation initiation factor 4E; Mechanistic target of rapamycin; Mendelian randomization; Osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Density
  • Eukaryotic Initiation Factor-4E* / genetics
  • Humans
  • Lumbar Vertebrae
  • Osteoporosis* / genetics
  • Polymorphism, Single Nucleotide
  • Upper Extremity

Substances

  • Eukaryotic Initiation Factor-4E